The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2
Open accessAbstract
Cyclooxygenases (COX) play an important role in lipid signaling by oxygenating arachidonic acid to endoperoxide precursors of prostaglandins and thromboxane. Two cyclooxygenases exist which differ in tissue distribution and regulation but otherwise carry out identical chemical functions. The neutral arachidonate derivative, 2-arachidonylglycerol (2-AG), is one of two described endocannabinoids and appears to be a ligand for both the central (CB1) and peripheral (CB2) cannabinoid receptors. Here we report that 2-AG is a substrate for COX-2 and that it is metabolized as effectively as arachidonic acid. COX-2-mediated 2-AG oxygenation provides the novel lipid, prostaglandin H(2) glycerol ester (PGH(2)-G), in vitro and in cultured macrophages. PGH(2)-G produced by macrophages is a substrate for cellular PGD synthase, affording PGD(2)-G. Pharmacological studies reveal that macrophage production of PGD(2)-G from endogenous sources of 2-AG is calcium-dependent and mediated by diacylglycerol lipase and COX-2. These results identify a distinct function for COX-2 in endocannabinoid metabolism and in the generation of a new family of prostaglandins derived from diacylglycerol and 2-AG.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has also been shown to utilize 2-AG and AEA as substrates to generate prostaglandin-glycerol (PG-G) and prostaglandin ethanolamide (PG-EA), respectively (Kozak et al., 2002; Kozak et al., 2000).”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Kozak et al., 2000
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,763
Cyclooxygenase in biology and disease
Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R., Simon, L. S., Putte, L., & Lipsky, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,606
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,973
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,922
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,200
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.
Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop‐Bailey, D., Croxtall, J. D., & Willoughby, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2046 · Cited by 1,035
Flagged first, then by citations
Research works printed but not linked: 7
- Needleman, 1997, J. Rheumatol., 24 Suppl. 49, 6
- Kennedy, 1993, Biochem. Cell Biol., 197, 494
- Bisogno, 1999, Biochem. Cell Biol., 256, 377
- Marnett, 1984, Mol. Pharmacol., 26, 328
- Jeon, 1996, Mol. Pharmacol., 50, 334
- Bleasdale, 1990, J. Pharmacol. Exp. Ther., 255, 756
- Pinto, 1994, Mol. Pharmacol., 46, 516
Cited by
Sorted by citations
Items 101–200 of 393
Functional Characterization of Cyclooxygenase-2 Polymorphisms
Fritsche, E., Baek, S. J., King, L. M., Zeldin, D. C., Eling, T. E., & Bell, D. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29252-1 · Cited by 104
The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action
Fowler, C. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707379 · Cited by 104
Chemical stability of 2-arachidonylglycerol under biological conditions
Rouzer, C. A., Ghebreselasie, K., & Marnett, L. J. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00068-3 · Cited by 101
de Bus, I., Witkamp, R. F., Zuilhof, H. T., Albada, B., & Balvers, M. G. J. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106351 · Cited by 105
Yan, W., Jenkins, C. M., Han, X., Mancuso, D. J., Sims, H. F., Yang, K., & Gross, R. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502358200 · Cited by 100
Lipid Signaling and Synaptic Plasticity
Sang, N., & Chen, C. (2006) · The Neuroscientist · doi:10.1177/1073858406290794 · Cited by 98
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Cheung, K. A. K., Peiris, H. N., Wallace, G., Holland, O. J., & Mitchell, M. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236079 · Cited by 105
Molecular Mechanism and Cannabinoid Pharmacology
Schurman, L. D., Lu, D., Kendall, D. A., Howlett, A. C., & Lichtman, A. H. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_298 · Cited by 110
Wang, H., Xie, H., Sun, X., Kingsley, P. J., Marnett, L. J., Cravatt, B. F., & Dey, S. K. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.09.009 · Cited by 98
Straiker, A. J., Hu, S. S., Long, J. Z., Arnold, A., Wager‐Miller, J., Cravatt, B. F., & Mackie, K. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059030 · Cited by 100
Katz, P. S., Sulzer, J. K., Impastato, R. A., Teng, S. X., Rogers, E., & Molina, P. E. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3508 · Cited by 97
O’Donnell, V. B., & Murphy, R. C. (2012) · Blood · doi:10.1182/blood-2012-04-402826 · Cited by 96
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
Brown, I. M., Cascio, M. G., Rotondo, D., Pertwee, R. G., Heys, S. D., & Wahle, K. W. J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.10.001 · Cited by 98
Esterified eicosanoids: Generation, characterization and function
Hammond, V. J., & O’Donnell, V. B. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.12.013 · Cited by 97
Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 103
Woodward, D. F., Carling, R. W., Cornell, C. L., Fliri, H. G., Martos, J. L., Pettit, S. N., Liang, Y., & Wang, J. W. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.001 · Cited by 92
Malcher‐Lopes, R., Franco, A. J., & Tasker, J. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.033 · Cited by 92
Hewett, S. J., Bell, S. C., & Hewett, J. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.011 · Cited by 91
Sang, N., Zhang, J., & Chen, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04668.x · Cited by 90
Sang, N., Zhang, J., & Chen, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105569 · Cited by 89
Monoacylglycerol signalling and ABHD6 in health and disease
Poursharifi, P., Madiraju, S. R. M., & Prentki, M. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13008 · Cited by 96
Wang, H., Hitron, I. M., Iadecola, C., & Pickel, V. M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhi008 · Cited by 92
Xie, S., Borazjani, A., Hatfield, M. J., Edwards, C. C., Potter, P. M., & Ross, M. K. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1002194 · Cited by 87
Group XV phospholipase A2, a lysosomal phospholipase A2
Shayman, J. A., Kelly, R., Kollmeyer, J., He, Y. O., & Abe, A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.10.006 · Cited by 84
Hösl, K., Reinold, H., Harvey, R., Müller, U., Narumiya, S., & Zeilhofer, H. (2006) · Pain · doi:10.1016/j.pain.2006.06.011 · Cited by 90
Kamble, R. D., Meshram, R. J., Hese, S. V., More, R. A., Kamble, S. S., Gacche, R. N., & Dawane, B. S. (2016) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2016.01.007 · Cited by 84
Alger, B. E. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.220855 · Cited by 82
Selective Oxygenation of the Endocannabinoid 2-Arachidonylglycerol by Leukocyte-Type 12-Lipoxygenase
Moody, J. S., Kozak, K. R., Ji, C., & Marnett, L. J. (2000) · Biochemistry · doi:10.1021/bi002303b · Cited by 81
Doenni, V. M., Gray, J. M., Song, C. M., Patel, S., Hill, M. N., & Pittman, Q. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.152 · Cited by 80
Endocannabinoid-Based Therapies
Piomelli, D., & Tagne, A. M. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-021800 · Cited by 82
Architecture of cannabinoid signaling in mouse retina
Hu, S. S., Arnold, A., Hutchens, J. M., Radicke, J., Cravatt, B. F., Wager‐Miller, J., Mackie, K., & Straiker, A. J. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22429 · Cited by 76
Hernangómez, M., Carrillo-Salinas, F. J., Mecha, M., Correa, F., Mestre, L., Loría, F., Feliú, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77
Darmani, N. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.34 · Cited by 77
Mounsey, R. B., Mustafa, S., Robinson, L., Ross, R. A., Riedel, G., Pertwee, R. G., & Teismann, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.07.024 · Cited by 75
Chen, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108394 · Cited by 78
Loss of Cannabinoid Receptor CB1 Induces Preterm Birth
Wang, H., Xie, H., & Dey, S. K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003320 · Cited by 74
Klinger-Gratz, P. P., Ralvenius, W. T., Neumann, E., Kato, A., Nyilas, R., Lele, Z., Katona, I., & Zeilhofer, H. U. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1945-17.2017 · Cited by 80
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
Ramer, R., Schwarz, R., & Hinz, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00430 · Cited by 75
Schmid, H. H. O., Schmid, P. C., & Berdyshev, E. V. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00157-3 · Cited by 71
Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2
Prusakiewicz, J. J., Kingsley, P. J., Kozak, K. R., & Marnett, L. J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00915-4 · Cited by 71
Ho, W. ‐. V., & Randall, M. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707141 · Cited by 71
The Endocannabinoid System as a Therapeutic Target in Glaucoma
Cairns, E. A., Baldridge, W. H., & Kelly, M. E. M. (2016) · Neural Plasticity · doi:10.1155/2016/9364091 · Cited by 76
Eicosanoids: Generation and Detection in Mammalian Cells
O’Donnell, V. B., Maskrey, B. H., & Taylor, G. W. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-115-8_1 · Cited by 71
Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid Anandamide
Kozak, K. R., Prusakiewicz, J. J., Rowlinson, S. W., Prudhomme, D. R., & Marnett, L. J. (2003) · Biochemistry · doi:10.1021/bi034471k · Cited by 68
Monoglyceride lipase: Structure and inhibitors
Scalvini, L., Piomelli, D., & Mor, M. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.07.011 · Cited by 69
Duarte, C. D., Tributino, J. L. M., Lacerda, D. I., Martins, M. V., Alexandre‐Moreira, M. S., Dutra, F., Bechara, E. J. H., De-Paula, F. S., Goulart, M. O. F., Ferreira, J., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.013 · Cited by 67
Functionalization of β-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System
Chicca, A., Caprioglio, D., Minassi, A., Petrucci, V., Appendino, G., Taglialatela‐Scafati, O., & Gertsch, J. (2014) · ACS Chemical Biology · doi:10.1021/cb500177c · Cited by 67
Gauthier, K. M., Baewer, D. V., Hittner, S. B., Hillard, C. J., Nithipatikom, K., Reddy, D. S., Falck, J. R., & Campbell, W. B. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00537.2004 · Cited by 66
Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol
Kozak, K. R., Prusakiewicz, J. J., Rowlinson, S. W., Schneider, C. G., & Marnett, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104467200 · Cited by 66
Simard, M., Archambault, A., Lavoie, J.-P. C., Dumais, É., Marzo, V. D., & Flamand, N. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115261 · Cited by 69
COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity
Yang, H., Zhang, J., Andreasson, K. I., & Chen, C. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.12.019 · Cited by 66
COX‐1 Inhibitors: Beyond Structure Toward Therapy
Vitale, P., Panella, A., Scilimati, A., & Perrone, M. G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21389 · Cited by 66
Alvarez‐Jaimes, L., Stouffer, D. G., & Parsons, L. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06301.x · Cited by 62
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
Vanegas, H., Vázquez, E., & Tortorici, V. (2010) · Pharmaceuticals · doi:10.3390/ph3051335 · Cited by 66
Chouinard, F., Lefebvre, J. S., Navarro, P., Bouchard, L., Ferland, C., Lalancette–Hébert, M., Marsolais, D., Laviolette, M., & Flamand, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002853 · Cited by 62
Frungieri, M. B., González-Calvar, S. I., Parborell, F., Albrecht, M., Mayerhofer, A., & Calandra, R. S. (2006) · Endocrinology · doi:10.1210/en.2006-0090 · Cited by 60
Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology
Nagaoka, M., Sakai, Y., Nakajima, M., & Fukami, T. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116128 · Cited by 64
Zeng, H., Liu, X., Dou, S., Xu, W., Li, N., Liu, X., Zhang, W., Hu, Z., & Liu, R. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.12.0016 · Cited by 59
Straiker, A. J., Wager‐Miller, J., Hu, S. S., Blankman, J., Cravatt, B., & Mackie, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01486.x · Cited by 58
Investigating Substrate Promiscuity in Cyclooxygenase-2
Vecchio, A. J., Orlando, B. J., Nandagiri, R., & Malkowski, M. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372243 · Cited by 58
The Structural Basis of Endocannabinoid Oxygenation by Cyclooxygenase-2
Vecchio, A. J., & Malkowski, M. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.230367 · Cited by 58
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
Fitzgibbon, M., Finn, D. P., & Roche, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv095 · Cited by 60
Escobar, W., Ramirez, K., Avila, C., Limongi, R., Vanegas, H., & Vázquez, E. (2011) · European Journal of Pain · doi:10.1002/j.1532-2149.2011.00057.x · Cited by 61
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Gamble-George, J. C., Baldi, R., Halladay, L., Kocharian, A., Hartley, N., Silva, C. G., Roberts, H., Haymer, A., Marnett, L. J., Holmes, A., et al. (2016) · eLife · doi:10.7554/elife.14137 · Cited by 55
Koda, N., Tsutsui, Y., Niwa, H., Ito, S., Woodward, D. F., & Watanabe, K. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.02.009 · Cited by 54
Psychopharmacology of the endocannabinoids: far beyond anandamide
Pamplona, F. A., & Takahashi, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405357 · Cited by 61
Müller cells express the cannabinoid CB2 receptor in the vervet monkey retina
Bouskila, J., Javadi, P., Casanova, C., Ptito, M., & Bouchard, J. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23333 · Cited by 55
Komoto, J., Yamada, T., Watanabe, K., Woodward, D. F., & Takusagawa, F. (2006) · Biochemistry · doi:10.1021/bi051861t · Cited by 53
Targeting the endocannabinoid system as a potential anticancer approach
Schwarz, R., Ramer, R., & Hinz, B. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1428344 · Cited by 55
Aldrovandi, M., Hammond, V. J., Podmore, H., Hornshaw, M. P., Clark, S., Marnett, L. J., Slatter, D. A., Murphy, R. C., Collins, P. W., & O’Donnell, V. B. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m041533 · Cited by 51
Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
Kesner, A. J., & Lovinger, D. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15369 · Cited by 58
Glycerylprostaglandin Synthesis by Resident Peritoneal Macrophages in Response to a Zymosan Stimulus
Rouzer, C. A., & Marnett, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501021200 · Cited by 51
Mitchell, M. D., Sato, T. A., Wang, A. T., Keelan, J. A., Ponnampalam, A. P., & Glass, M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2007 · Cited by 52
Coevolution between cannabinoid receptors and endocannabinoid ligands
McPartland, J. M., Norris, R. W., & Kilpatrick, C. W. (2007) · Gene · doi:10.1016/j.gene.2007.04.017 · Cited by 51
Moriuchi, H., Koda, N., Okuda‐Ashitaka, E., Daiyasu, H., Ogasawara, K., Toh, H., Ito, S., Woodward, D. F., & Watanabe, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705638200 · Cited by 47
Thuresson, E. D., Malkowski, M. G., Lakkides, K. M., Rieke, C. J., Mulichak, A. M., Ginell, S. L., Garavito, R. M., & Smith, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009378200 · Cited by 48
Rouzer, C. A., & Marnett, L. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.198 · Cited by 48
Vannacci, A., Giannini, L., Passani, M. B., Felice, A. D., Pierpaoli, S., Zagli, G., Fantappiè, O., Mazzanti, R., Masini, E., & Mannaioni, P. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068635 · Cited by 47
Paria, B. C., Wang, H., & Dey, S. K. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00156-1 · Cited by 47
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
Appiah‐Kusi, E., Leyden, E., Parmar, S. R., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2015) · Psychological Medicine · doi:10.1017/s0033291715001786 · Cited by 46
Rouzer, C. A., Kingsley, P. J., Wang, H., Zhang, H., Morrow, J. D., Dey, S. K., & Marnett, L. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402594200 · Cited by 46
Cannabinoid CB 1 receptors mediate the effects of dipyrone
Crunfli, F., Vilela, F. C., & Giusti‐Paiva, A. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12347 · Cited by 45
Endocannabinoids and Acute Pain Following Total Knee Arthroplasty
Azim, S., Nicholson, J., Rebecchi, M., Galbavy, W., Feng, T., Reinsel, R., Volkow, N., Benveniste, H., & Kaczocha, M. (2015) · Pain · doi:10.1097/01.j.pain.0000460315.80981.59 · Cited by 37
Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
Melgar‐Lesmes, P., Perramón, M., & Jiménez, W. (2019) · Cells · doi:10.3390/cells8111311 · Cited by 45
Ramer, R., Brune, K., Pahl, A. M., & Hinz, B. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5518 · Cited by 44
Wang, J., Shen, R., & Haj‐Dahmane, S. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.238659 · Cited by 43
Kingsley, P. J., Rouzer, C. A., Saleh, S., & Marnett, L. J. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.05.005 · Cited by 43
Díez-Dacal, B., & Pérez‐Sala, D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.69 · Cited by 43
Chouinard, F., Turcotte, C., Guan, X., Larose, M.-C., Poirier, S. J., Bouchard, L., Provost, V., Flamand, L., Grandvaux, N., & Flamand, N. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412200 · Cited by 43
Liu, X., Moon, S. H., Jenkins, C. M., Sims, H. F., & Gross, R. W. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.08.009 · Cited by 42
Quehenberger, O., Dahlberg-Wright, S., Jiang, J., Armando, A. M., & Dennis, E. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.d089516 · Cited by 43
Chapter 13 The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways
Smith, W. L., & Murphy, R. C. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)36015-0 · Cited by 42
Chen, L., Yan, Y., Chen, T., Zhang, L., Gao, X., Du, C., & Du, H. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.02.008 · Cited by 39
Nitro-imidazole-based ruthenium complexes with antioxidant and anti-inflammatory activities
Sasahara, G. L., Júnior, F. S. G., Rodrigues, R. D. O., Zampieri, D., Fonseca, S. G. D. C., Gonçalves, R. D. C. R., Athaydes, B. R., Kitagawa, R. R., Santos, F. A., Sousa, E. H. S., et al. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111048 · Cited by 40
RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-α secretion
Rouzer, C. A., Jacobs, A. T., Nirodi, C. S., Kingsley, P. J., Morrow, J. D., & Marnett, L. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500006-jlr200 · Cited by 40
Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6
Brüser, A., Zimmermann, A., Crews, B. C., Sliwoski, G. R., Meiler, J., König, G. M., Kostenis, E., Lede, V., Marnett, L. J., & Schöneberg, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-02414-8 · Cited by 41
Khasabova, I. A., Uhelski, M. L., Khasabov, S. G., Gupta, K., Seybold, V. S., & Simone, D. A. (2019) · Blood · doi:10.1182/blood-2018-11-884346 · Cited by 39
Vila, A., Rosengarth, A., Piomelli, D., Cravatt, B. F., & Marnett, L. J. (2007) · Biochemistry · doi:10.1021/bi7005898 · Cited by 37
The Multiple Pathways of Endocannabinoid Metabolism: A Zoom Out
Vandevoorde, S., & Lambert, D. M. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790156 · Cited by 43
The role of endocannabinoids in pregnancy
Chan, H., McKirdy, N. C., Peiris, H. N., Rice, G. E., & Mitchell, M. D. (2013) · Reproduction · doi:10.1530/rep-12-0508 · Cited by 38
Metadata
- Authors
- Kozak, K. R., Rowlinson, S. W., & Marnett, L. J.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Marnett, Lawrence J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-10
- Volume
- 275
- Issue
- 43
- Pages
- 33744-33749
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2086458197
- Cited by
- 390
- References
- 44
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 18 · 2021: 13 · 2020: 16 · 2019: 14 · 2018: 10 · 2017: 17 · 2016: 18 · 2015: 15 · 2014: 16 · 2013: 19 · 2012: 18
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r35ca047479-10)
- National Cancer Institute (CA-47479, CA 68484, P01CA068484)
- National Institute of Environmental Health Sciences (ES00267)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- 2-arachidonoylglycerol, endocannabinoids, cyclooxygenase-2, endocannabinoid metabolism, macrophages, diacylglycerol lipase, lipid signaling, arachidonic acid oxygenation
- MeSH terms
- Animals, Arachidonic Acids, Binding Sites, Cell Line, Glycerides, Humans, Isoenzymes, Male, Membrane Proteins, Prostaglandin-Endoperoxide Synthases, Sheep, Prostaglandin D2, Mice, Cyclooxygenase 1, Cyclooxygenase 2, Cannabinoid Receptor Modulators, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review